Print  |  Close

Phase 1 Study of ADI PEG 20 Plus FOLFOX in Subjects With Advanced Gastrointestinal Malignancies

Active: Yes
Cancer Type: Pancreatic Cancer
Stomach/ Gastric Cancer
NCT ID: NCT02102022
Trial Phases: Phase I Protocol IDs: POLARIS2013-001 (primary)
Eligibility: 18 Years and older, Male and Female Study Type: Treatment
Study Sponsor: Polaris Group
NCI Full Details:


Assessment of safety and tolerability of ADI-PEG 20 in combination with folinic acid (leucovorin), fluorouracil and oxaliplatin (FOLFOX) in advanced GI malignancies.